ACTUATE THERAPEUTICS
Company Overview
Social Media Profiles
About Actuate Therapeutics
Description
Actuate Therapeutics focuses on developing innovative treatments for hard-to-treat cancers. The company's lead drug, elraglusib, targets multiple molecular pathways, aiming to improve patient outcomes and enhance the quality of life for individuals battling difficult cancers.
Specialties
Innovative cancer therapies
Elraglusib drug development
Targeting multiple molecular pathways
Focus on hard-to-treat cancers
Improving patient quality of life
Products & Services
Elraglusib
Cancer Treatment Development
Clinical Trials
Biopharmaceutical Research
Molecular Pathway Targeting
Contact Information
Email Addresses
Competitors & Similar Companies(8)
Mediinal Therapeutics
Caris Life Sciences
Iovance Biotherapeutics
California, • United States
Adaptimmune
Pennsylvania, • United States
Zymework
British Columbia, • Canada
Karyopharm Therapeutics
Massachusetts, • United States
Infinity Pharmaceuticals
Massachusetts, • United States
Blueprint Medicines
Massachusetts, • United States
News & Media
Search Terms:
actuate therapeutics
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Actuate Therapeutics
Where is Actuate Therapeutics located?
The headquarter of Actuate Therapeutics is located in Fort Worth, Texas, United States
What is the email address of Actuate Therapeutics?
The email addresses of Actuate Therapeutics are [email protected]
What is the official website of Actuate Therapeutics?
The official website of Actuate Therapeutics is https://www.actuatetherapeutics.com
What industry does Actuate Therapeutics belong to?
Actuate Therapeutics belongs to the Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Actuate Therapeutics?
Actuate Therapeutics specializes in Innovative cancer therapies, Elraglusib drug development, Targeting multiple molecular pathways, Focus on hard-to-treat cancers, Improving patient quality of life.
What products and services is Actuate Therapeutics likely to offer?
Actuate Therapeutics offers Elraglusib, Cancer Treatment Development, Clinical Trials, Biopharmaceutical Research, Molecular Pathway Targeting.
Who are the competitors of Actuate Therapeutics?
Competitors of Actuate Therapeutics are Mediinal Therapeutics, Caris Life Sciences, Iovance Biotherapeutics, Adaptimmune, Zymework, Karyopharm Therapeutics, Infinity Pharmaceuticals, Blueprint Medicines.
What does Actuate Therapeutics do?
Actuate Therapeutics focuses on developing innovative treatments for hard-to-treat cancers. The company's lead drug, elraglusib, targets multiple molecular pathways, aiming to improve patient outcomes and enhance the quality of life for individuals battling difficult cancers.